Transparency was the buzzword at Thursday's Senate health committee hearing as lawmakers made their first move toward increasing reporting demands for hospitals in the 340B drug discount program.
Congress failed to approve a measure that would provide another avenue for terminally ill patients to get access to experimental drugs.
Martin Shkreli, the smirking "Pharma Bro" vilified for jacking up the price of a lifesaving drug, was sentenced Friday to seven years in prison for defrauding investors in two failed hedge funds.
UnitedHealthcare, the nation's biggest health insurer, will pass drugmaker rebates along to some customers starting next year, giving a potential break to those taking expensive prescriptions.
Companies that distribute drugs are pushing back on stricter regulation in Ohio, protesting what they call a patchwork approach that could lead to confusion and uncertainty, records show.
The Justice Department will support local officials in hundreds of lawsuits against manufacturers and distributors of powerful opioid painkillers that are fueling the nation's drug abuse crisis.
It's Rare Disease Week and Rare Disease Day is Feb. 28, both of which are aimed at highlighting the difficulty and costliness of treating rare conditions.
Modern Healthcare's CEO Power Panel survey indicates healthcare leaders still fear unbridled drug costs and wonder if the industry has reached a breaking point.
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses. Preliminary figures released Thursday suggest the vaccine is 36% effective overall in preventing flu illness severe enough to send a patient to the doctor's office.
Providers should not expect to see lower drug prices from a potential Walgreens Boots Alliance and AmerisourceBergen Corp. deal, analysts say.
Proteus makes digital sensors for pills that track medication adherence, including in Abilify Mycite, the first of such drugs to receive FDA approval.
President Donald Trump has tapped deputy White House chief of staff Jim Carroll to serve as the administration's next drug czar, making him the most public face of the administration's efforts to fight the opioid epidemic.